[ad_1]
Continuous innovation and creativity will be important in finding a solution that puts an end to the pandemic and minimizes its impact.
As the world faces one of the most serious healthcare challenges of this generation, an increasing number of technology companies are working to help combat the COVID-19 pandemic. Continuous innovation and creativity will be important in finding a solution that puts an end to the pandemic and minimizes its impact.
This week, IBM signed the Open COVID Commitment, providing free access to the company’s wide patent portfolio for those who develop technologies for diagnosis, prevention, localization or treatment. The participation covers thousands of IBM artificial intelligence patents, including Watson technology patents, and over 900 active US patents. UU. in the general field of biological viruses.
: Grifols processing for COVID-19 may be ready in July Read more
IBM is committed to providing scientists and researchers with the tools and resources to combat COVID-19. Participating in the promise is in addition to other technologies IBM has already provided to assist in these efforts, including the launch of the high-performance computing consortium COVID-19, which offers an unprecedented amount of computing power to help researchers better understand COVID-19, its treatment and possible cures.
IBM’s commitment to the promise strengthens our commitment to delivering the technological resources people need at the forefront. To learn more about Open COVID Pledge, visit the blog: https://www.ibm.com/blogs/research/2020/04/ibm-patent-portfolio-access-combat-covid-19.
YOU MAY INTERESTED
[ad_2]
